Webinars

Winning Strategies in the Next Decade in Pathology: Enterprise‑Wide Operational Readiness, AI‑Powered Digital Workflows, and Predictive AI‑Driven CDx

Anil Parwani, MD, PhD, MBA ,
Chair of Pathology at The Ohio State University
Derek Welch, MD ,
President and Chief Medical Officer at PathGroup
Mohamed Salama, MD ,
Chief Medical Officer at Sonic Healthcare USA
Mark Frushone ,
Global Director of Commercial Development Digital Pathology, Leica Biosystems

Fast Forward to Next Generation Imaging - The Leica Biosystems Solution Bringing Your Digital Pathology to the Next Level.

Mark Green
Sara van den Boomen ,
Digital Pathology Sales Specialist, UK

The Cutting-Edge Technology of AI Prostate Cancer Diagnosis in the Era of Digital Pathology

Mr. Sunwoo Kim ,
PhD

How Integration Helps to Adopt Digital Pathology

Prof. Dr. Peter Schüffler, PhD

Demystifying DICOM in Digital Pathology: Experiences from the National Pathology Imaging Co-operative

Dr Craig Sayers, MD

Experience Next Generation Imaging - Leica Biosystems latest Digital Pathology solution built with pathologist in mind

Sai Ram Prakash Chandrasekaran

COVID-19 Response and the (Remote) Use of Digital Pathology

Lance Mikus ,
MBA

The Value of an RTU

The Value of an RTU

Novocastra p16 Antibody Demonstrated an Agreement of 98% with the Roche p16 Antibody

Dr. Selvam Thavaraj ,
PhD FDSRCS FRCPath

Novocastra p16 antibody demonstrated an agreement of 98% with the Roche p16 antibody The study compared the percentage agreement rates of Novocastra’s p16 (6H12) IVD solution with Roche CINtec® Histology p16 assay on 170 oropharyngeal cancer cases.